President Donald Trump’s recent executive order on childhood vaccinations has sparked a predictable debate concerning public health priorities, parental rights, and the scientific basis for the directive. The order calls for changes to the U.S. childhood immunization schedule, including splitting the combined measles, mumps, and rubella (MMR) vaccine into separate doses. From an immunologist’s perspective, the order runs counter to established scientific consensus and promotes claims lacking evidentiary support.
Yet the more pressing concern raised by the order is fundamental: what occurs when vaccine policy is detached from the scientific processes intended to inform it?
For decades, the United States has depended on a transparent process whereby scientists, physicians, public health officials, and vaccine experts evaluate evidence and formulate recommendations regarding vaccine recipients and timing. Disagreements within this process are not only expected but valuable, as constructive debate can improve policy. Substituting expert scientific review with political directives, however, risks establishing a precedent that could reach far beyond vaccination policy.
Avery August
President of the American Association of Immunologists
Dr. Avery August serves as the 2026‑2027 President of the American Association of Immunologists, holds an HHMI professorship, acts as deputy provost, and is a professor in the Department of Microbiology and Immunology at Cornell University. Previously, he was a distinguished professor of immunology in the Department of Veterinary and Biomedical Sciences and director of the Center for Molecular Immunology and Infectious Disease at Pennsylvania State University’s University Park campus, where he began his career as an assistant professor. He earned a B.S. in medical technology from California State University, Los Angeles, and a Ph.D. in immunology from the Weill Cornell Graduate School of Medical Sciences.
The immediate impact of the executive order may be limited. Many pediatricians, state public health agencies, and professional medical organizations are likely to continue adhering to established immunization schedules, which have been shaped by decades of scientific review and practical experience. The order does not automatically alter how vaccines function, how physicians practice medicine, or how states determine school vaccination requirements.
Although the order outlines numerous changes, it lacks direct authority to modify vaccine recommendations. At present, those recommendations remain safeguarded by federal law; the order can influence direction but cannot establish policy.
It would be erroneous to dismiss the order as inconsequential, given that its primary risk lies in sowing confusion and uncertainty among parents and caregivers who seek to safeguard their children’s health.
Vaccination programs depend on a fragile element: public confidence. That confidence can be eroded quickly. Parents deserve reliable information when making health decisions for their children, and physicians must trust that vaccine schedules reflect the best available scientific evidence. Undermining this trust will likely exacerbate declines in vaccination rates, even absent formal mandate changes.
This trend is already evident. U.S. kindergarten vaccination rates continue to decline, falling further below the thresholds required for herd immunity. The situation is particularly alarming given that the United States is enduring one of its most severe measles outbreaks in decades, alongside a resurgence of other preventable infectious diseases.
The executive order calls for separating the combined measles, mumps, and rubella (MMR) vaccine into three individual doses—a move that highlights the core issue. Although presented as a means to reduce the number of childhood immunizations, the proposal would, in practice, increase the total number of shots required.
The rationale is straightforward. Currently, children receive two doses of the combined MMR vaccine during their early years, delivered as two injections. Under the order’s approach, achieving equivalent protection would necessitate six separate injections.
The changes to the childhood vaccination schedule proposed in the executive order are not backed by scientific evidence.
(Image credit: adamkaz via Getty Images)
The order further recommends administering each immunization during separate medical visits, which would triple the number of appointments required to attain the same protection. For families, this means additional time away from work, more missed school days, increased transportation expenses, higher co‑payments for those whose insurance plans mandate them, and greater likelihood of postponed or missed appointments.
These practical consequences should not be overlooked. Each extra visit presents another opportunity for a child to fall behind on vaccinations, and each added logistical barrier disproportionately impacts families with limited resources, less flexible schedules, or reduced access to healthcare.
Moreover, the individual vaccines necessary to implement this policy are not presently available in the United States. Manufacturers would need to develop new production processes, conduct testing, navigate regulatory approval, and establish distribution networks for these separate vaccines—all to replace a combined vaccine that has demonstrated an outstanding safety and effectiveness record for over fifty years.
In essence, the proposal would introduce substantial new costs and complexity merely to supplant a system that has functioned exceptionally well and protected children for decades. The combined MMR vaccine was created specifically because combining vaccines reduces the number of injections, thereby improving vaccination rates by ensuring children receive protection as early and efficiently as possible.
What matters more is whether recommendations are supported by evidence and whether they effectively protect children in America, specifically.
What justification underlies the executive order? Administration officials have cited discrepancies between U.S. vaccine recommendations and those of certain other developed nations, such as Denmark, which advises fewer routine vaccinations than the United States. At first glance, this argument may appear reasonable—if another country administers fewer doses, why should the U.S. not follow suit?
The reality is that vaccine timing and dosage are tailored to each country’s distinct healthcare systems and public health contexts. Nations vary in disease prevalence, healthcare access, vaccine delivery mechanisms, screening initiatives, and population demographics. Some countries benefit from more centralized healthcare systems that facilitate preventive‑care follow‑up, whereas others confront different infectious‑disease challenges than those faced by the United States.
Consequently, variation in vaccination schedules across nations is expected, and the impulse to align U.S. schedules with those of other countries is arbitrary rather than grounded in science. What truly matters is whether recommendations are supported by evidence and whether they effectively protect American children.
The full impact of this executive order—and the broader challenges to vaccination—may not become apparent for months or years. It will likely manifest as eroding confidence in public health institutions, heightened uncertainty among families, and greater difficulty sustaining high vaccination rates, ultimately resulting in increased incidence of disease and mortality.
This is why the executive order warrants attention.
Whether formal policy changes occur immediately or later is secondary; the greater concern is whether the order will encourage Americans to depend less on scientific evidence and expertise when making decisions that affect their children’s health.
I contend that immunology constitutes a critical scientific foundation underpinning modern medicine. Vaccine policy ought to be constructed upon this foundation, allowing scientific evidence to guide public‑health recommendations. Should this foundation falter, the cost will be measured in lives lost to preventable disease—a future we must strive to prevent.
